Regulated expression of sFRP-1 protein by the GeneSwitch system

被引:10
作者
Bhat, RA [1 ]
Stauffer, B [1 ]
Komm, BS [1 ]
Bodine, PVN [1 ]
机构
[1] Wyeth Ayerst Res, Womens Hlth Res Inst, Collegeville, PA 19426 USA
关键词
D O I
10.1016/j.pep.2004.06.029
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The GeneSwitch system is a mifepristone-inducible expression system that provides exceptionally low uninduced and high-induced protein expression in mammalian cells. We have developed an adenovirus recombinant containing GeneSwitch protein driven by the GAL4-tk promoter, as well as recombinants containing sFRP-1 and luciferase reporter under the control of the GAL4-E1b promoter. Luciferase activity in A549 cells infected with the GeneSwitch and Luciferase viruses is very low in ethanol-treated cells, while the level of luciferase activity increases 200-fold in cells treated with mifepristone. Conditional expression of functional sFRP-1 is demonstrated in A549, human osteoblast, and CHO cell lines by either the co-infection of cells with sFRP-1 and GeneSwitch viruses or the infection of GeneSwitch expressing cell lines with sFRP-1 virus and subsequent treatment with mifepristone. The expression of sFRP-1 is seen as early as 4h post-mifepristone treatment, reaching the highest levels at 20h. The sFRP-1 protein is present in conditioned media, and the protein is functional based upon its ability to inhibit the Wnt-mediated activation of TCF-Luciferase reporter activity. The regulated expression of sFRP-1 utilizing adenovirus vectors provides an opportunity to address the contribution of sFRP-1 in the regulation of stem cell differentiation, maturation, and their function by modulating the Writ signaling. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:327 / 335
页数:9
相关论文
共 43 条
[11]  
Chuah Marinee K. L., 2003, Current Gene Therapy, V3, P527, DOI 10.2174/1566523034578140
[12]  
Church VL, 2002, INT J DEV BIOL, V46, P927
[13]  
Duplàa C, 1999, CIRC RES, V84, P1433
[14]   Secreted frizzled related protein 1 is overexpressed in uterine leiomyomas, associated with a high estrogenic environment and unrelated to proliferative activity [J].
Fukuhara, K ;
Kariya, M ;
Kita, M ;
Shime, H ;
Kanamori, T ;
Kosaka, C ;
Orii, A ;
Fujita, J ;
Fujii, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1729-1736
[15]  
Furukawa Kiyoshi, 1992, Current Opinion in Biotechnology, V3, P554, DOI 10.1016/0958-1669(92)90085-W
[16]   TRANSCRIPTIONAL ACTIVATION BY TETRACYCLINES IN MAMMALIAN-CELLS [J].
GOSSEN, M ;
FREUNDLIEB, S ;
BENDER, G ;
MULLER, G ;
HILLEN, W ;
BUJARD, H .
SCIENCE, 1995, 268 (5218) :1766-1769
[17]   Tissue restricted expression of two human Frzbs in preadipocytes and pancreas [J].
Hu, ED ;
Zhu, Y ;
Fredrickson, T ;
Barnes, M ;
Kelsell, D ;
Beeley, L ;
Brooks, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (02) :287-293
[18]  
Ijiri K, 2002, J RHEUMATOL, V29, P2266
[19]   Expression pattern of mouse sFRP-1 and mWnt-8 gene during heart morphogenesis [J].
Jaspard, B ;
Couffinhal, T ;
Dufourcq, P ;
Moreau, C ;
Duplàa, C .
MECHANISMS OF DEVELOPMENT, 2000, 90 (02) :263-267
[20]   Secreted antagonists of the Wnt signalling pathway [J].
Kawano, Y ;
Kypta, R .
JOURNAL OF CELL SCIENCE, 2003, 116 (13) :2627-2634